KÜNSTLICHE NUKLEINSÄUREMOLEKÜLE ZUR VERBESSERTEN PROTEIN- ODER PEPTIDEXPRESSION

European patent · EP3578659 · In force

Register entry

Publication number
EP3578659
Application number
EP19171200
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 27, 2013
Published
Dec 11, 2019
Granted
Nov 1, 2023
Protection ends at the latest
Mar 26, 2033
Next annual fee due
Mar 31, 2027
IPC classes
C12N 15/67 (2006.01)
Priority
WO PCT/EP2012/001336 27.03.2012
WO PCT/EP2012/002447 08.06.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 28, 2026

    Change

    Published in Swissreg on 28.05.2026

  2. Apr 29, 2025

    Change

    Published in Swissreg on 29.04.2025

  3. Sep 11, 2024

    Change

    Published in Swissreg on 11.09.2024

  4. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  5. Jan 17, 2024

    Agent entered

    Representative
    Swisspat Riederer Hasler Patentanwälte AG, Kappelestrasse 17, 9492 Eschen, Liechtenstein

    Published in Swissreg on 17.01.2024

  6. Nov 1, 2023

    Granted

    Published in Swissreg on 01.11.2023

Parties

Holder

CureVac SE

Friedrich-Miescher-Straße 15, 72076 Tübingen, DE

Agent

Swisspat Riederer Hasler Patentanwälte AG

Kappelestrasse 17, 9492 Eschen, LI

Inventor

Theß, Andreas

72706 Tübingen, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.